Sanofi, Translate in mRNA vaccines deal

Translate Bio Inc. (Lexington, Mass.) partnered with the Sanofi Pasteur division of Sanofi (Euronext:SAN; NYSE:SNY) to develop mRNA vaccines against up to five undisclosed pathogens for infectious diseases.

Translate is to receive $45 million up front and is eligible for $760 million in milestones and option fees, plus tiered royalties. Sanofi Pasteur will fund joint R&D and will receive exclusive, worldwide rights to commercialize vaccines developed under the three-year deal...